Oct 10 (Reuters) - VALBIOTIS SA ALVAL.PA :
* VALBIOTIS LAUNCHES A CAPITAL INCREASE WITH MAINTENANCE OF
THE
RIGHT PREFERENTIAL SUBSCRIPTION (SDA)
* SUBSCRIPTION PRICE : EUR 2.35 PER SHARE
* SUBSCRIPTION PERIOD: FROM OCTOBER 16, 2019 TO OCTOBER 28,
2019
INCLUSIVE
* CAPITAL INCREASE OF EUR 7.2 MILLION WHICH MAY BE INCREASED
TO
EUR 8.3 MILLION IN EVENT OF EXERCISE OF THE EXTENSION CLAUSE
* NEW STRATEGIC PRIORITY: CONCLUDE BEFORE END-2020
PARTNERSHIP
WITH MAJOR HEALTHCARE PLAYER THAT WILL PROVIDE FUNDING NEEDED TO
FINALIZE CLINICAL DEVELOPMENT OF VALEDIA
* AROUND 2/3 TO BE DEDICATED TO RESEARCH AND DEVELOPMENT,
1/3 TO
"MARKET ACCESS"
Source text: https://bit.ly/2IEXIU9
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))